A Comparison of Adherence and CD4 Cell Count with Respect to Virologic Failure Among HIV-Infected Adults Under Combination Antiretroviral Therapy (cART) at Felege Hiwot Teaching and Specialized Hospital, Bahir Dar, Ethiopia
Open Access
- 1 February 2022
- journal article
- research article
- Published by Taylor & Francis in HIV/AIDS - Research and Palliative Care
- Vol. ume 14, 33-44
Abstract
Background: Medication adherence plays a significant in the success of combination antiretroviral therapy (cART). Therefore, the current investigation was conducted with the objective of comparing adherence and CD4 cell count with respect to virologic failure among HIV-infected adults under cART. Methods: A retrospective study design was conducted on 792 randomly selected HIV-infected adult patients who initiated first-line cART enrolled in the first 10 months of 2012 and followed up to August 2018 by using a simple random sampling technique based on their identification number. Results: The main outcome for the current investigation was the virologic failure which was decreased with successive visits. The area under the receiver operating characteristic curve for adherence and CD4 cell count change were 0.68 and 0.63 with χ2 = 21.2; p-value < 0.001 for the 12-month assessment. Similarly, these areas for the 36th and 60th month assessments were 0.71 and 0.66, with χ2 = 23.2; p-value < 0.001, and 0.73 and 0.71 with χ2 = 24.3; p-value < 0.001 for adherence and CD4 cell count, respectively. Conclusion: Pill count adherence was more accurate compared to CD4 cell count change for assessing virologic responses. Therefore, because of its easy access, simple use, cost-effectiveness, and accuracy, the adherence to cART was in favor of CD4 cell count change for monitoring the healthcare quality of HIV-infected patients.Keywords
This publication has 30 references indexed in Scilit:
- Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?BMC Medicine, 2013
- Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysisBMC Medicine, 2013
- Pharmacy Refill Adherence Compared with CD4 Count Changes for Monitoring HIV-Infected Adults on Antiretroviral TherapyPLOS Medicine, 2008
- CD4+ Count–Guided Interruption of Antiretroviral TreatmentNew England Journal of Medicine, 2006
- Less Than 95% Adherence to Nonnucleoside Reverse‐Transcriptase Inhibitor Therapy Can Lead to Viral SuppressionClinical Infectious Diseases, 2006
- Adherence to Highly Active Antiretroviral Therapy Assessed by Pharmacy Claims Predicts Survival in HIV-Infected South African AdultsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Self-Report Measures of Antiretroviral Therapy Adherence: A Review with Recommendations for HIV Research and Clinical ManagementAIDS and Behavior, 2006
- Paradoxes of adherence and drug resistance to HIV antiretroviral therapyJournal of Antimicrobial Chemotherapy, 2004
- Prognostic Value of Plasma Human Immunodeficiency Virus Type 1 (HIV-l) RNA Levels in Patients with Advanced HIV-l Disease and with Little or No Prior Zidovudine TherapyThe Journal of Infectious Diseases, 1996
- Better Bootstrap Confidence IntervalsJournal of the American Statistical Association, 1987